76667-68-0

Upstream product

• 100-39-0 benzyl bromide 
• 76667-04-4 3,4-dihydro-6,7-dimethoxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide 
• 6315-89-5 3,4-dimethoxyaniline 
• 76666-93-8 α-Chlor-β-(3,4-dimethoxy-6-chlorsulfonylphenyl)propionsaeureamid 
• 14612-07-8 α-Chlor-β-(3,4-dimethoxyphenyl)propionsaeurenitril 
• 76666-96-1 α-Chlor-β-(3,4-dimethoxy-6-N-benzylsulfamoyl)propionsaeureamid 
• 76667-91-9 C₁₁H₁₃N₂O₅S^(1-)*K⁽¹⁺⁾ 

Downstream Products

• 76685-06-8 3,4-dihydro-6,7-dimethoxy-2-benzyl-2H-1,2-benzothiazine-3-carboxylic acid 1,1-dioxide 
• 376389-39-8 N-(2-benzyl-3,4-dihydro-6,7-dimethoxy-2H-1,2-benzothiazine-3-carbonyl)-L-phenylalaninol 1,1-dioxide 

Relevant academic research and scientific papers

1,2-Benzothiazine 1,1-dioxide P2-P3 peptide mimetic aldehyde calpain I inhibitors

A series of peptide mimetic aldehyde inhibitors of calpain I was prepared in which the P2 and P3 amino acids were replaced by substituted 3,4-dihydro-1,2-benzothiazine-3-carboxylate 1,1-dioxides. The effect of 2, 6, and 7-benzothiazi

BENZOTHIAZO AND RELATED HETEROCYCLIC GROUP-CONTAINING CYSTEINE AND SERINE PROTEASE INHIBITORS

The present invention is directed to novel benzothiazo and related heterocyclic group-containing inhibitors of cysteine or serine proteases. Methods for using the same are also described.

Derivatives of 6,7-dimethoxy-1-thiaisochroman-1,1-dioxide and 3.4-dihydro-6,7-dimethoxy-2H-1,2-benzothiazine-1,1-dioxide (author's transl)

The authors deal with the synthesis of 3-substituted 6,7-dimethoxy-1-thiaisochroman-1,1-dioxide and 3,4-dihydro-6,7-dimethoxy-2H-1,2-benzothiazine-1,1-dioxide derivatives. The compounds in the first-named group were found to exert effects on the central n